Harvard University homepage
HARVARD.EDU

HUHS Appoints Chief Medical Officer and Deputy Executive Director

  • Publication date September 7, 2023
Healthcare business concept, Medical examination and graph data growth of business on tablet with doctor's health report clipboard on background

Harvard University Health Services (HUHS) recently announced two additions to its senior leadership team. Kathy G. Niknejad, MD, will serve as Chief Medical Officer (CMO) and Physician in Chief, and Kimberly Eng will serve as Deputy Executive Director and Chief Administrative Officer. HUHS is a multispecialty practice that provides medical and mental health care to the Harvard…Continue Reading HUHS Appoints Chief Medical Officer and Deputy Executive Director

HUHS Face Mask Policy Update

  • Publication date May 10, 2023
Behavioral Health Image

As you may be aware, the World Health Organization (WHO) declared an end to the international COVID-19 health emergency on May 5. This indicates that, like other established health issues, COVID-19 will move towards long-term management. Additionally, on May 11, both Massachusetts and the federal government will lift the COVID-19 public health emergency. These changes will impact policies…Continue Reading HUHS Face Mask Policy Update

Public Health Guidance for Commencement and Year-End Activities

  • Publication date May 8, 2023

As we approach the end of the academic year and prepare to gather in celebration for Commencement and other events, I write to share with you some important public health updates. On May 11, the Commonwealth of Massachusetts and the federal government will end their Public Health Emergency for COVID-19. This will change the response to COVID-19 and will…Continue Reading Public Health Guidance for Commencement and Year-End Activities

Statement on National Stimulant Medication Shortage

  • Publication date April 12, 2023

Statement on National Stimulant Medication Shortage HUHS is aware of the current national shortage of prescription stimulant medications such as Adderall, Ritalin, Concerta Methylphenidate, Vyvanse and Dextroamphetamine and Amphetamine. These drugs are typically used in the treatment of Attention-Deficit/Hyperactivity Disorder. Drug manufacturers have been unable to produce sufficient quantities to meet current patient needs.  Although HUHS…Continue Reading Statement on National Stimulant Medication Shortage

Health and Safety Recommendations for Winter Recess

  • Publication date December 6, 2022
Winter background with snow and a snowperson

Health and Safety Recommendations for Winter Recess As members of the Harvard community depart campus to gather with family and friends, remember to continue taking steps to protect yourselves, your colleagues, and your loved ones from COVID-19 as well as other circulating respiratory illness—like RSV and influenza. Influenza activity in the U.S. has been elevated for several weeks,…Continue Reading Health and Safety Recommendations for Winter Recess